PharmiNews

The Directory of Pharma Companies and News

Amgen

Amgen logo
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Category: Pharmaco
Category: Pharmaco

Amgen News

DateNews
2017-07-31Amgen Submits Supplemental Biologics License Application For Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis
2017-07-31Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration
2017-07-28Amgen Announces 2017 Third Quarter Dividend
2017-07-27FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha® (evolocumab) To Include D...
2017-07-25Amgen Reports Second Quarter 2017 Financial Results
2017-07-20FDA Accepts Biologics License Application For Aimovig™ (erenumab)
2017-07-20Amgen Announces Webcast of 2017 Second Quarter Financial Results
2017-07-18Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation
2017-07-16Amgen And UCB Provide Update On Regulatory Status Of EVENITY™ (romosozumab) In The US
2017-07-14Amgen Submits Regulatory Applications In US And Europe To Include Overall Survival Data In KYPROLIS® (Carfilzomib) Label
2017-07-13Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avast...
2017-07-12FDA Grants Full Approval for BLINCYTO® (blinatumomab) to Treat Relapsed or Refractory B-cell Precursor Acute Lymphoblast...
2017-07-12Second Phase 3 Study Shows KYPROLIS® (Carfilzomib) Regimen Significantly Improves Overall Survival In Patients With Rela...
2017-07-11Amgen And QB3@953 Announce Winners Of The Amgen Golden Ticket
2017-06-29FDA Approves Vectibix® (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer
2017-06-23Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara® (cinacalcet) For The Treatment Of Secondary Hyperparathyr...
2017-06-21Amgen To Present New Data At 22nd Congress of the European Hematology Association
2017-06-19FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® (denosumab) To Include Mu...
2017-06-08Amgen Presents Erenumab Data At The 59th Annual Scientific Meeting of the American Headache Society
2017-06-08Amgen To Present At The Goldman Sachs 38th Annual Global Healthcare Conference
2017-06-07Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab
2017-06-05Amgen Submits Regulatory Applications For Repatha® (evolocumab) Cardiovascular Outcomes Data In US And Europe
2017-06-04Amgen Presents New Data From Phase 3 XGEVA® (Denosumab) Study In Patients With Multiple Myeloma At ASCO 2017
2017-06-03Amgen Presents New Phase 2 Data On IMLYGIC® (Talimogene Laherparepvec) Investigational Combination At ASCO 2017
2017-06-02Amgen Showcases A Legacy Of Science, Innovation And Collaboration In Cambridge
2017-05-21Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY™ (Romosozumab) In Postmenopausal Wo...
2017-05-20Repatha® (Evolocumab) Reduced Cardiovascular Events In Patients With Baseline LDL-C Levels Below Current Targets
2017-05-19Amgen Announces Voting Results of Annual Meeting of Stockholders
2017-05-18Amgen Submits Biologics License Application To The FDA For Erenumab
2017-05-17Amgen Highlights Data To Be Presented At ASCO 2017 Across Oncology Portfolio
2017-05-12Amgen To Present At The Bank Of America Merrill Lynch 2017 Health Care Conference
2017-05-02Amgen And Harvard Pilgrim Agree To First Cardiovascular Outcomes-Based Refund Contract For Repatha® (Evolocumab)
2017-04-27Amgen To Participate In The 2017 World Medical Innovation Forum™ Focused On Cardiovascular Disease
2017-04-26Amgen Reports First Quarter 2017 Financial Results
2017-04-24Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine
2017-04-21Amgen Announces Webcast Of 2017 First Quarter Financial Results
2017-04-18Amgen Launches Neulasta® (pegfilgrastim) Onpro® NARRATIVES
2017-04-04Amgen Submits Applications In The US And Europe To Expand Current Indication For XGEVA® (denosumab) To Include Patients ...
2017-04-01Amgen And UCB Report New Data At ENDO 2017 Examining The Option Of A Second Course Of Treatment With EVENITY™ (romosozum...
2017-03-31Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting
2017-03-29FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
2017-03-29Journal Of Clinical Oncology Publishes Data On BLINCYTO® (Blinatumomab) In High-Risk Patients With Philadelphia Chromoso...
2017-03-28Amgen Awards Three Golden Tickets for LabCentral Residency
2017-03-23European Commission Approves AMGEVITA™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
2017-03-19Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patient...
2017-03-18Lowering LDL Levels With Repatha® (Evolocumab) Did Not Adversely Affect Cognitive Function In Landmark Phase 3 Study
2015-10-13Amgen Announces 2015 Fourth Quarter Dividend
2015-10-12New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteopo...
2015-10-12Amgen And LabCentral Announce 2015 Golden Ticket Winners
2015-10-11New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
2015-10-06Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary
2015-10-06New Data Show Greater Bone Mineral Density Gains With Prolia® (Denosumab) Compared With Zoledronic Acid
2015-10-02Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research A...
2015-09-25Amgen To Present At The Barclays Biosimilars Symposium
2015-09-23Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop
2015-09-23Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe
2015-09-18Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215
2015-09-16Amgen To Acquire Privately-Held Dezima Pharma
2015-09-16FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib...
2015-09-15Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation
2015-09-14Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference
2015-09-11Amgen To Present At The Morgan Stanley Global Healthcare Conference
2015-09-11Amgen Highlights Key Clinical Data To Be Presented At European Cancer Congress 2015
2015-09-02Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)
2015-09-01Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs
2015-09-01Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The Euro...
2015-08-27Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide
2015-08-25Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015
2015-08-25FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab)
2015-08-18Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416)
2015-07-30Amgen Announces Appointment Of Fred Hassan To Board Of Directors
2015-07-30Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizat...
2015-07-28Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased...
2015-07-27Amgen Announces 2015 Third Quarter Dividend
2015-07-24Amgen Announces Webcast of 2015 Second Quarter Financial Results
2015-07-23FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma
2015-07-21Amgen Submits Supplemental New Drug Application For Kyprolis® (Carfilzomib) In Relapsed Multiple Myeloma
2015-07-16European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibito...
2015-06-19Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphi...
2015-06-18Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of Episodic Migraine
2015-06-10Results From Phase 3 Trial Show Vectibix® (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Meta...
2015-06-08Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol
2015-06-05Amgen To Present At The Goldman Sachs Global Healthcare Conference
2015-06-01Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherpa...
2015-06-01Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholest...
2015-05-31Amgen Presents Phase 3 Data At ASCO Showing Prolia® (Denosumab) Significantly Reduced Bone Fractures In Breast Cancer Pa...
2015-05-29Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec In Combination With K...
2015-05-29Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Mu...
2015-05-28Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic K...
2015-05-27Amgen To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-27Amgen Launches Program To Further Advance Basic Biology Research
2015-05-26Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European Hematology Association (EH...
2015-05-22Amgen to terminate participation in co-development and commercialization of brodalumab
2015-05-22Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Respons...
2015-05-18Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol
2015-05-15Amgen Appoints Jonathan P. Graham Senior Vice President, General Counsel And Secretary
2015-05-14Amgen Presents First Phase 2 Data For AMG 334 In The Prevention Of Episodic Migraine
2015-05-13Amgen Announces Voting Results of Annual Meeting of Stockholders
2015-05-12Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio
2015-05-11Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide Search For Champions In The Fight Against Cancer
2015-05-04Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society
2015-04-29Amgen Announces FDA Advisory Committee Meeting To Review Repatha™ (Evolocumab) As A Treatment For High Cholesterol
2015-04-29Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference
2015-04-21Amgen To Discuss Details Of The Biologics License Application For Talimogene Laherparepvec For Patients With Metastatic ...
2015-04-16Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased...
2015-04-15Amgen Announces Webcast Of 2015 First Quarter Financial Results
2015-04-06FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With C...
2015-03-30Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference
2015-03-30European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemoth...
2015-03-26FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Rela...
2015-03-25Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Cham...
2015-03-23The Genomic Portrait of a Nation
2015-03-20Amgen To Webcast Investor Call At the 73rd Annual Meeting of the American Academy of Dermatology
2015-03-17Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In Japan
2015-03-15Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Derma...
2015-03-14Amgen Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha™ (evolocumab) In The New Engl...
2015-03-04New Detailed Data From Phase 3 Study Show Amgen's Repatha™ (Evolocumab) In Combination With Statins Reduced LDL-C By 67-...
2015-03-02Amgen Announces 2015 Second Quarter Dividend
2015-03-02Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data
2015-03-01Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit
2015-02-27Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Pa...
2015-02-26Amgen Receives Positive CHMP Opinion For Use Of Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLF...
2015-02-25Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing Authorization Application ...
2015-02-25Amgen Announces Positive Results From Head-To-Head Study Comparing The Efficacy And Safety Of AMG 416 With Cinacalcet In...
2015-02-11Amgen To Present At The Cowen And Company 35th Annual Health Care Conference
2015-02-03Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic...
2015-01-29Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ...
2015-01-27Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosi...
2015-01-27Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myelo...
2015-01-22Amgen's 2014 Revenues Increased 7 Percent To $20.1 Billion And Adjusted Earnings Per Share (EPS) Increased 14 Percent To...
2015-01-15Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results
2015-01-12Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With...
2015-01-08Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome
2015-01-05Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference
1970-01-01New data presented by Mundipharma highlights a portfolio with cost efficient therapies (PDF)
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.